293: Josh Wolfe On Investing In Frontier Technology

— Science advances through challenging consensus, not following it; established institutions resist paradigm shifts because their status depends on existing frameworks.

— Venture capital success depends primarily on backing exceptional people rather than technology alone; teams can pivot and find solutions when initial approaches fail.

— Cross-disciplinary breakthroughs happen at the intersection of fields (telescopes + biology imaging, video gaming + gesture interfaces), creating opportunities others miss.

— Finding "outcasts" and contrarian thinkers—those rejected by mainstream consensus—often leads to discovering transformative companies before the market recognizes value.

— Bitcoin and crypto represent a generational shift in monetary belief systems away from fiat currency, competing with gold as protection against currency debasement; adoption depends on intersubjective belief, not technology alone.

— Genetic sequencing of rare human populations could unlock monogenic disease targets; combining computational biology with traditional medicine dramatically accelerates drug discovery.

— When evaluating contrarian founders and technologies, fund to milestones rather than fully upfront; this forces accountability and prevents confirmation bias that has enabled frauds like Theranos.

— Seek investments where two arrows intersect: inevitable directional progress (e.g., lighting, vehicles, storage) and perception of impossibility by the market; this combination signals information arbitrage and undervaluation.

— Monitor leadership responses to criticism—transparency and "open kimono" (full disclosure) defuse skepticism, while attacking critics signals a red flag similar to predatory institutions.